PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
MID vs. UTHR
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between MID and UTHR is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

MID vs. UTHR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in American Century Mid Cap Growth Impact ETF (MID) and United Therapeutics Corporation (UTHR). The values are adjusted to include any dividend payments, if applicable.

-10.00%-5.00%0.00%5.00%10.00%15.00%20.00%25.00%AugustSeptemberOctoberNovemberDecember2025
3.97%
11.12%
MID
UTHR

Key characteristics

Sharpe Ratio

MID:

1.46

UTHR:

2.35

Sortino Ratio

MID:

2.06

UTHR:

3.06

Omega Ratio

MID:

1.25

UTHR:

1.43

Calmar Ratio

MID:

1.12

UTHR:

2.64

Martin Ratio

MID:

8.34

UTHR:

12.40

Ulcer Index

MID:

2.89%

UTHR:

5.28%

Daily Std Dev

MID:

16.56%

UTHR:

27.98%

Max Drawdown

MID:

-40.15%

UTHR:

-93.18%

Current Drawdown

MID:

-5.79%

UTHR:

-11.05%

Returns By Period

In the year-to-date period, MID achieves a 1.72% return, which is significantly lower than UTHR's 3.36% return.


MID

YTD

1.72%

1M

-2.96%

6M

3.98%

1Y

24.87%

5Y*

N/A

10Y*

N/A

UTHR

YTD

3.36%

1M

0.80%

6M

11.12%

1Y

66.49%

5Y*

31.25%

10Y*

9.99%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

MID vs. UTHR — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MID
The Risk-Adjusted Performance Rank of MID is 6565
Overall Rank
The Sharpe Ratio Rank of MID is 6969
Sharpe Ratio Rank
The Sortino Ratio Rank of MID is 6868
Sortino Ratio Rank
The Omega Ratio Rank of MID is 6464
Omega Ratio Rank
The Calmar Ratio Rank of MID is 5252
Calmar Ratio Rank
The Martin Ratio Rank of MID is 7272
Martin Ratio Rank

UTHR
The Risk-Adjusted Performance Rank of UTHR is 9494
Overall Rank
The Sharpe Ratio Rank of UTHR is 9696
Sharpe Ratio Rank
The Sortino Ratio Rank of UTHR is 9393
Sortino Ratio Rank
The Omega Ratio Rank of UTHR is 9393
Omega Ratio Rank
The Calmar Ratio Rank of UTHR is 9494
Calmar Ratio Rank
The Martin Ratio Rank of UTHR is 9494
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

MID vs. UTHR - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for American Century Mid Cap Growth Impact ETF (MID) and United Therapeutics Corporation (UTHR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for MID, currently valued at 1.46, compared to the broader market0.002.004.001.462.35
The chart of Sortino ratio for MID, currently valued at 2.06, compared to the broader market-2.000.002.004.006.008.0010.0012.002.063.06
The chart of Omega ratio for MID, currently valued at 1.25, compared to the broader market0.501.001.502.002.503.001.251.43
The chart of Calmar ratio for MID, currently valued at 1.12, compared to the broader market0.005.0010.0015.001.122.64
The chart of Martin ratio for MID, currently valued at 8.34, compared to the broader market0.0020.0040.0060.0080.00100.008.3412.40
MID
UTHR

The current MID Sharpe Ratio is 1.46, which is lower than the UTHR Sharpe Ratio of 2.35. The chart below compares the historical Sharpe Ratios of MID and UTHR, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio1.001.502.002.503.00AugustSeptemberOctoberNovemberDecember2025
1.46
2.35
MID
UTHR

Dividends

MID vs. UTHR - Dividend Comparison

MID's dividend yield for the trailing twelve months is around 0.17%, while UTHR has not paid dividends to shareholders.


TTM20242023
MID
American Century Mid Cap Growth Impact ETF
0.17%0.17%0.02%
UTHR
United Therapeutics Corporation
0.00%0.00%0.00%

Drawdowns

MID vs. UTHR - Drawdown Comparison

The maximum MID drawdown since its inception was -40.15%, smaller than the maximum UTHR drawdown of -93.18%. Use the drawdown chart below to compare losses from any high point for MID and UTHR. For additional features, visit the drawdowns tool.


-14.00%-12.00%-10.00%-8.00%-6.00%-4.00%-2.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-5.79%
-11.05%
MID
UTHR

Volatility

MID vs. UTHR - Volatility Comparison

The current volatility for American Century Mid Cap Growth Impact ETF (MID) is 5.45%, while United Therapeutics Corporation (UTHR) has a volatility of 8.36%. This indicates that MID experiences smaller price fluctuations and is considered to be less risky than UTHR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%AugustSeptemberOctoberNovemberDecember2025
5.45%
8.36%
MID
UTHR
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab